Home » Topics » Regulatory » Patents

Patents
RSS

Hanlin Scientific patents agents for cancer and amyloidosis

Jan. 9, 2017

Corsair Pharma reports prostacyclin analogues for PAH

Jan. 9, 2017

TGR5 modulators described in Intercept/Servier patent

Jan. 9, 2017

Astex Pharmaceuticals and GSK describe NRF2 regulators

Jan. 9, 2017

Lilly patents somatostatin sst5 receptor antagonists

Jan. 9, 2017

Orion presents Bdr4 inhibitors

Jan. 9, 2017

FORUM Pharmaceuticals discloses compounds dor Alzheimer's disease

Jan. 5, 2017

Bayer Pharma describes anticancer agents

Jan. 5, 2017

Vascular Strategies patents mTOR inhibitors

Jan. 5, 2017

Global Blood Therapeutics develops KLKB1 inhibitors

Jan. 5, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...